WASHINGTON--(BUSINESS WIRE)--Certain controversial elements of the patent ‘reform’ legislation pending before the Congress would sharply increase patent costs and risks, undermining innovation with potentially serious consequences for the U.S. economy, concluded two independent experts in a new analysis released today by the Biotechnology Industry Organization (BIO).
